Study on regulation and molecular mechanism of osteoclast development and function induced by Prostaglandin

点击翻译按钮获取中文摘要

Prostaglandin (PG) E2 is a known bone absorbing agent that act on osteoblasts to facilitate osteoclastogenesis by increasing the secretion of RANKL. In the present study, we investigated the direct action of PGE2 on osteoclastic progenitors that differentiate into TRAP-positive multinucleated cells. The hematopoietic stem cell obtained from murine bone : marrow was purified by a Sephadex-GlO column, and cultured in the presence of CSF-1 and RANKL to facilitate cell differentiation. The introduction of low-density PGE2 into the culture resulted in a drastic increase of TRAP-positive multinucleated cells, whereas the addition of high-density PGE2 had the opposite effect. PCR analysis revealed increased level of EP3 mRNA in undifferentiated cells and reduced level after the development of osteoclast ; EP1, EP2 and EP4 were constitutively expressed throughout the differentiation. Investigation of intracellular signaling verified that low-density PGE2 suppressed PKA activity in undifferentiated cells, suggesting that PGE2 acts on the osteoclastic cell lineage to facilitate cell differentiation by suppressing PKA in the presence of RANKL.